SCHEMBL6502899

SCHEMBL6502899

CN(C)C1=C(NC(=O)C(Cl)c2ccccc2)C(=O)c2ccccc2C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
HTT P42858 7/20 0.47
LMNA P02545 5/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
NOD2 Q9HC29 1/20 0.47
HSP90AA1 P07900 4/20 0.41
HSP90AB1 P08238 4/20 0.41
RAB9A P51151 4/20 0.41
GAA P10253 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 8/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
NPSR1 Q6W5P4 3/20 0.40
NSD2 O96028 2/20 0.40
POLB P06746 1/20 0.40
APAF1 O14727 3/20 0.40
CASP3 P42574 2/20 0.40
SENP8 Q96LD8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6500883 0.86 ALDH1A1 (0.48) ALDH1A1HTTLMNAL3MBTL1NOD2
SCHEMBL6505425 0.80 HSP90AA1 (0.61) ALDH1A1HTTLMNAL3MBTL1HSP90AA1
SCHEMBL6508853 0.77 ALDH1A1 (0.41) ALDH1A1HTTLMNAL3MBTL1NOD2
SCHEMBL6509320 0.76 TDP2 (0.49) ALDH1A1HTTLMNAL3MBTL1NOD2
SCHEMBL31171425 0.72 MEN1 (0.55) ALDH1A1HTTLMNAL3MBTL1RAB9A
SCHEMBL6240247 0.69 MAOA (0.49) ALDH1A1HTTLMNAL3MBTL1NOD2
SCHEMBL10465216 0.69 POLB (0.66) ALDH1A1HTTLMNAHSP90AA1RAB9A
SCHEMBL29967684 0.68 HKDC1 (0.51) ALDH1A1HTTLMNAL3MBTL1RAB9A
SCHEMBL6039993 0.67 LMNA (0.53) ALDH1A1HTTLMNAHSP90AA1GAA
SCHEMBL4819698 0.66 CYP1A2 (0.58) ALDH1A1HTTLMNARAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032794-A1 Diamine derivatives of quinone and uses thereof CLINICAL DATA, INC. 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032794-A1 Diamine derivatives of quinone and uses thereof NQO1, DPYD, NQO2 ALDH1A1 128/4885HTT 3519/4885LMNA 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.